Investors are coming off of a rough Tuesday, which saw the recent market sell-off come back in full force after two winning sessions.
Related Posts
Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance
Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.
From EVs to beauty: Strategist names four stocks to buy in 2025
There will be “significant opportunities” for stock pickers in 2025, according to Michele Schneider.
Some ‘Trump trades’ are starting to roll over as the stock market sputters
Small caps and industrials are among the stock groups that are now down since Election Day.